For informational and research purposes only. Not medical advice. Content is aggregated from public sources. Always consult a qualified healthcare provider.
Performance & Growth Hormone · Comparison

CJC-1295 + GHRP-6 Stack vs Sermorelin

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

CJC-1295 + GHRP-6 StackSermorelin
CategoryPerformance & Growth HormonePerformance & Growth Hormone
Also known asCJC GHRP-6 combination, GH releasing stack, GHRH GHRP combination, CJC-1295 GHRP-6GHRH 1-29, GRF 1-29 NH2, Geref
EvidenceResearch-stageFDA-approved
Dosing rangeCJC-1295 100mcg + GHRP-6 100mcg–CJC-1295 200mcg + GHRP-6 300mcg mcg, 1–3x daily (pre-sleep, pre-workout, morning)100mcg–500mcg mcg, once daily (before sleep)
AdministrationSubcutaneous injectionSubcutaneous injection
Key side effectsStrong appetite stimulation (GHRP-6 dominant effect), Water retention, Tingling / numbness in extremities, Mild cortisol elevation (GHRP-6 is less selective than ipamorelin)Injection site redness, Headache, Flushing, Dizziness
Cited sources2 references1 reference

Key differences

  • Evidence level differs: CJC-1295 + GHRP-6 Stack is research-stage, while Sermorelin is fda-approved.
  • Frequency: CJC-1295 + GHRP-6 Stack is typically 1–3x daily (pre-sleep, pre-workout, morning); Sermorelin is once daily (before sleep).
  • Research depth: this profile cites 2 sources for CJC-1295 + GHRP-6 Stack vs 1 for Sermorelin.

How each works

CJC-1295 + GHRP-6 Stack

The GHRH + GHRP combination synergistically amplifies GH pulse amplitude compared to either agent alone. CJC-1295 elevates baseline GH via GHRH receptor signaling at the pituitary; GHRP-6 triggers pulse timing via GHS-R1a. GHRP-6's potent appetite stimulation (significantly stronger than ipamorelin) makes this combination preferred in protocols targeting caloric surplus and mass accumulation.

Sermorelin

Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.

Read the full CJC-1295 + GHRP-6 Stack profileRead the full Sermorelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.